|
| legal_US = Schedule I
| legal_UN = Narcotic Schedules I and IV
| dependency_liability = Physicalਸਰੀਰਕ: Veryਬਹੁਤ ਜ਼ਿਆਦਾ high<br />Psychologicalਮਾਨਸਿਕ: Very highਬਹੁਤ ਜ਼ਿਆਦਾ
| addiction_liability = Very highਬਹੁਤ ਜ਼ਿਆਦਾ
| routes_of_administration = Inhalationਸਾਹ ਰਾਹੀਂ ਧੂਆਂ ਖਿਚਣਾ, transmucosal, intravenous, oralਮੂੰਹ ਰਾਹੀਂ, intranasal, rectal, intramuscular
<!--Pharmacokinetic data-->
| bioavailability = <35% (oralਮੂੰਹ ਰਾਹੀਂ), 44–61% (inhaledਸਾਹ ਰਾਹੀਂ)<ref name="pmid16433897">{{cite journal | author = Rook EJ, van Ree JM, van den Brink W, Hillebrand MJ, Huitema AD, Hendriks VM, Beijnen JH | title = Pharmacokinetics and pharmacodynamics of high doses of pharmaceutically prepared heroin, by intravenous or by inhalation route in opioid-dependent patients | journal = Basic Clin. Pharmacol. Toxicol. | volume = 98 | issue = 1 | pages = 86–96 | year = 2006 | pmid = 16433897 | doi = 10.1111/j.1742-7843.2006.pto_233.x }}</ref>
| protein_bound = 0% ([[morphineਮਾਰਫੀਨ]] metabolite 35%)
| metabolism = [[hepatic]]
| elimination_half-life = 2–3 minutesਮਿੰਟ<ref name = EMC>{{cite web|title=Diamorphine Hydrochloride Injection 30 mg – Summary of Product Characteristics|work=electronic Medicines Compendium|publisher=ViroPharma Limited|date=24 September 2013|accessdate=30 March 2014|url=http://www.medicines.org.uk/emc/medicine/28258/SPC/Diamorphine+Hydrochloride+Injection+30+mg/}}</ref>
| excretion = 90% [[renal]] as [[glucuronide]]s, rest [[biliary]]
| 